About Citro Pharma Private Limited
Data last updated:
Citro Pharma Private Limited is a private limited company based in Bangalore, Karnataka, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 14 October 2016, the company has been in operation for over 10 years.
Registered with ROC Bangalore under CIN U24230KA2016PTC097166.
Capital: an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Shaikh Mukhtar Ahmed and Mukhtar Ahmed.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: No. 2/A 4Th Main Shampura K G Halli, Bangalore, Karnataka, India – 560045.
As per the financials filed for FY 2025, the company reported a revenue of ₹20.6 Cr, a growth of 3% compared to the previous year.
The company is associated with 1 brand - Citro Pharma.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website citropharm.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressNo. 2/A 4Th Main Shampura K G Halli, Bangalore, Karnataka, India – 560045
- IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Citro Pharma
Citro Pharma operates one associated brand: Citro Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Global manufacturer and exporter of pharmaceuticals, biopharmaceuticals, and vaccines. | citropharm.com |
Competitors & Alternatives of Citro Pharma
Brands and companies operating in the same space as Citro Pharma Private Limited include Neovacs, Yapanbio, VERAXA and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
 Neovacs | Vaccine manufacturing services are provided by Neovacs CDMO. | Paris, France, France | 1993 |
 Yapanbio | Contract manufacturing of bio-therapeutics and vaccines is provided. | Hyderabad, India, India | 2019 |
 VERAXA | Antibody therapeutics for cancer treatment are developed via microfluidic screening. | Heidelberg, Germany, Germany | 2017 |
 Fina Biosolutions | Biotechnology company specializing in bioconjugation services mainly for vaccine development | Rockville, United States, United States | 2006 |
 Primrose Bio | New molecules are discovered, developed, and manufactured in biotechnology. | San Diego, United States, United States | 2023 |
 Intravacc | Vaccine development services for bacterial and viral vaccines are provided. | Bilthoven, Netherlands, Netherlands | 2012 |
 Imophoron | CDMO focused on manufacturing of vaccines | Bristol, United Kingdom, United Kingdom | 2017 |
 VaxForm | Vaccine formulation development and consulting services are offered. | Lehigh, United States, United States | 2010 |
 WestVac Biopharma | COVID-19 vaccines are manufactured via CDMO services by WestVac Biopharma. | Lanzhou, China, China | 2021 |
Business Activity of Citro Pharma
The main business activity of Citro Pharma is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | Locked |
Business activity turnover details for Citro Pharma Private Limited
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Citro Pharma
Citro Pharma Private Limited is audited by BPSSY&CO for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| BPSSY&CO | Locked | Locked | Locked |
Complete auditor history for Citro Pharma Private Limited
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Citro Pharma Private Limited
Citro Pharma has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shaikh Mukhtar Ahmed | Director | 14 Oct 2016 | 9 Years 11 Months | Current |
| Mukhtar Ahmed | Director | 14 Oct 2016 | 9 Years 11 Months | Current |
| Ashfaq Ahmed | Director | 14 Oct 2016 | 9 Years 11 Months | Current |
Financials of Citro Pharma Private Limited FY 2025 filings available
Citro Pharma Private Limited reported revenue of ₹20.6 Cr (up 3.00% YoY) for FY 2025.
Ten-year financial statements for Citro Pharma Private Limited
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Citro Pharma
Shareholding and ownership data for Citro Pharma Private Limited
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Citro Pharma
Citro Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Citro Pharma
Employment history and EPFO contributions of people linked to Citro Pharma.
Employee and EPFO history for Citro Pharma Private Limited
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Citro Pharma
GST registrations and filing compliance for Citro Pharma Private Limited
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Citro Pharma
Credit ratings, litigation, and regulatory alerts for Citro Pharma Private Limited
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Citro Pharma
MSME payment history for Citro Pharma Private Limited
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Citro Pharma
Corporate group structure for Citro Pharma Private Limited
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Citro Pharma
MCA filings and documents for Citro Pharma Private Limited
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Citro Pharma
Frequently Asked Questions about Citro Pharma Private Limited
Citro Pharma is an active private limited company in the pharma sector based in Bangalore, Karnataka, India. It was incorporated on 14 October 2016 (10+ years old) and is registered under CIN U24230KA2016PTC097166.
Citro Pharma reported revenue of ₹20.6 Cr for FY 2025 (up 3.00% YoY).
The current directors of Citro Pharma are:
- Shaikh Mukhtar Ahmed - Director
- Mukhtar Ahmed - Director
- Ashfaq Ahmed - Director
The primary industry of Citro Pharma is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Citro Pharma can be reached at the registered office: No. 2A 4Th Main Shampura K G Halli, Bangalore, Karnataka, India – 560045, or through the website citropharm.com.
The authorised capital is ₹1 Lakh, and the paid-up capital is ₹1 Lakh.